Department of Endocrinology, St Vincent's Hospital Melbourne, Fitzroy, Australia.
Department of Medicine, University of Melbourne, Fitzroy, Australia.
Diabetes Technol Ther. 2022 Jul;24(7):531-534. doi: 10.1089/dia.2021.0558. Epub 2022 Jun 6.
Devices have facilitated improvement in glycemia in individuals with type 1 diabetes mellitus (T1DM), but self-management remains key. It is unclear whether people review their device data before clinic appointment. We assessed this by a survey. T1DM adults using glucose sensors and/or insulin pumps attending an Australian public hospital (diabetes clinics >4 months) were prospectively surveyed. The percentage who uploaded and reviewed their data was determined and their interest in education facilitating understanding of their device data was assessed. Of 138 adults (100% participation rate), 79% uploaded and 32% reviewed their device data before their clinic appointments. Individuals using pumps with sensors were most likely to review their data. Median HbA levels were lower in those who did versus did not review their device data (50.8 vs. 61.8 mmol/mol, = 0.0001). Most (89%) were interested in education. Although diabetes technology has improved glycemia in T1DM, the benefits may be maximized through device-specific education programs enhancing self-management.
设备已帮助 1 型糖尿病（T1DM）患者改善血糖水平，但自我管理仍然是关键。目前尚不清楚人们在就诊前是否会查看设备数据。我们通过调查对此进行了评估。正在使用血糖传感器和/或胰岛素泵的 T1DM 成年患者参加了澳大利亚一家公立医院（糖尿病诊所>4 个月）的前瞻性调查。确定了上传和查看数据的百分比，并评估了他们对有助于了解设备数据的教育的兴趣。在 138 名成年人中（参与率为 100%），79%上传了设备数据，32%在就诊前查看了设备数据。使用带传感器的泵的患者最有可能查看其数据。与未查看设备数据的患者相比，查看设备数据的患者的 HbA1c 水平中位数更低（50.8 与 61.8mmol/mol，=0.0001）。大多数患者（89%）对教育感兴趣。尽管糖尿病技术改善了 T1DM 的血糖水平，但通过增强自我管理的设备特定教育计划，可能会最大程度地提高这些益处。
